Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion.
about
A phase I and pharmacokinetic study of intraperitoneal topotecanA Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumors.A phase I study to characterize the safety, tolerability, and pharmacokinetics of topotecan at 4 mg/m2 administered weekly as a 30-minute intravenous infusion in patients with cancer.A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumoursA review of topotecan in combination chemotherapy for advanced cervical cancerMultipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer.Topotecan: a new topoisomerase I inhibiting antineoplastic agent.Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol.Clinical pharmacology of camptothecins.
P2860
Q28366214-BC287E70-5C38-4C6A-9DF7-A9FA3BCDA6DCQ33339062-96B47D77-3A43-4FF8-93B9-A00D7BF22624Q33386523-1405D4F4-12B7-412B-A118-FE9FF5F5CEC5Q36614847-4A8A58B9-0C53-4210-AEFB-83BAB96E92C7Q36822899-9DC4CB4A-3140-4361-8276-8EF0913E0D29Q38871242-1881F82C-D71A-4EB4-91D8-BBF8B6E1BDC9Q42689189-572D311F-0A3B-4DBC-A4DD-4CACCC8FFE56Q46963348-F60E504C-C090-4BEC-B184-148DD4903E23Q53780736-4C4BBA97-6240-4F4C-8A06-9D9184D4EB8A
P2860
Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Phase I clinical and pharmacok ...... a 24-hour continuous infusion.
@ast
Phase I clinical and pharmacok ...... a 24-hour continuous infusion.
@en
type
label
Phase I clinical and pharmacok ...... a 24-hour continuous infusion.
@ast
Phase I clinical and pharmacok ...... a 24-hour continuous infusion.
@en
prefLabel
Phase I clinical and pharmacok ...... a 24-hour continuous infusion.
@ast
Phase I clinical and pharmacok ...... a 24-hour continuous infusion.
@en
P2093
P1476
Phase I clinical and pharmacok ...... a 24-hour continuous infusion.
@en
P2093
B E Davies
J H Beijnen
L J van Warmerdam
S Rodenhuis
W W ten Bokkel Huinink
P304
P356
10.1200/JCO.1995.13.7.1768
P407
P577
1995-07-01T00:00:00Z